PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing.

The Awards evening, back for its 24th year, began with a networking event, welcoming hundreds of guests dressed in smart evening wear who were eager to discover who the 2024 PMEA winners were.

The PMEA programme rewards work that delivers clearly identifiable benefits and improved outcomes for patients, as well as societal value, in global, regional and local markets.

This year’s Awards included 17 categories, up from 14 in 2023, with PMEA Company of the Year now split into small/medium companies and large companies. A new category recognising Excellence in Low- and Middle-Income Countries was also added.

Stand-up comedian Angela Barnes took to the stage after a formal dinner and was joined by this year’s chair, Stephanie Hall, founder and chief executive officer of Uptake.

Taking home the first award of the evening, Excellence in Engaging and Educating Patients, was ‘An Outbreak of Optimism: Raising Atopic Dermatitis Patients’ Hope for the Future’ by Sanofi and Regeneron, with support from Havas Lynx. The judges described the programme as a “well-planned and tailored long-term approach to support a huge drug launch” and noted that its results “demonstrated statistical significance and were hard to ignore”.

Excellence in Low- and Middle-Income Countries was won by Roche-Government Cote d’Ivoire Partnership by Roche, which the judges said had “extremely impressive public/private partnership and a clear needs assessment, conducted with stakeholders across government, non-governmental organisations, healthcare professionals and international partnership”.

The highly competitive Support Agency of the Year Award went to Possible. The panel said: “The [agency is] small and clearly focused, recently founded and with a strong growth trajectory delivering quality work and innovation.”

The final award of the evening, PMEA Company of the Year, was given to Amgen, which had a strong presence at this year’s Awards, having already taken the top spot in two categories. The judges were impressed by the company’s leadership team and recognised that it had “invested in marketing skills and customer closeness, adopting a strong cross-functional approach in engagement”.

An evening of dancing and networking followed, marking the conclusion of another successful PMEA.

1 Excellence in Engaging and Educating Patients
Winner 

• An Outbreak of Optimism: Raising Atopic Dermatitis Patients’ Hope for the Future by Sanofi and Regeneron with support from Havas Lynx

• The Red Flag Campaign: Elevating the Lived Experience of Endometriosis to Drive Early Diagnosis by Gedeon Richter with support from Inizio Evoke

• A Behavioural Science-led Approach to Improve Patient Self-management, Well-being and Treatment Persistence in Chronic Lymphocytic Leukaemia by AstraZeneca with support from Atlantis Health
• Novartis Patient Support Program – Hybrid Personalised Support at Patients’ Fingertips by Novartis with support from IQVIA

• Tillotts IDEAL Education by Tillotts Pharma UK

• Psa Consensus Programme: Shaping Real Clinical Practice on The Ground by Johnson & Johnson with support from Bedrock Healthcare Communications
• Creating Menopause Confident Prescribers for Improved Patient Outcomes by Theramex with support from The Studio × Uniphar

• Consensus Through Connectivity: National Alignment on the Optimal Treatment Journey in Fabry Disease by Takeda Pharmaceuticals
• Empowering IBD CNS to Lead Effectively by Takeda UK with support from The Healthy Team

• The Eyes Have It by Roche Products

• Unseen Unheard: The Untold Breast Cancer Stories of Black Women in the UK by Gilead Sciences with Black Women Rising with support from Mearns & Pike

• Lung Unlimited: Driving Scientific Exchange with Urgency and Imagination by AstraZeneca US Medical Affairs, Thoracic Oncology with support from Complete HealthVizion
• Retention Patch Program – Retaining Children in Clinical Trials Through the Power of Patches! by Innovative Trials

• Cancer Equals by Bristol Myers Squibb UK & Ireland with support from Aurora Healthcare Communications

• Living Well with Fabry: Shared Decision-Making Toolkit by Chiesi with support from Rare Disease Research Partners
• Patient Freedom with Care Closer to Home by Ipsen

• Swixx Rare Disease Academy – The Premier Educational Resource for Healthcare Professionals in Central and Eastern Europe by Swixx BioPharma

• Medscape Extend: Programmatically Engaging Conference Attendees at EAU 2024 by Medscape

• Cencora’s Biosimilar Hub on FormularyDecisions.com by Cencora
• Relapsing Multiple Sclerosis: Supporting Patients Every Step of the Way by EPG Health

• Sandoz BioZone – An Educational Initiative in Neurology by Sandoz with support from Syneos Health Communications

• Target Proteinuria by CSL Vifor with support from Havas Life Medicom
• CONNEXT: The New Home for Cardiovascular Care by Abbott with support from Precision AQ

• UK Launch of LIVTENCITY by Takeda UK with support from Precision AQ

• TAVNEOS – Successfully Navigating Uncharted Waters and Mapping a New Course that Transforms Care in ANCA-Associated Vasculitis by CSL Vifor with support from Havas Life Medicom

• The IGNITE Forum 2024 by Takeda with support from Emotive

• Swixx Rare Disease Academy – The Premier Educational Resource for Healthcare Professionals in Central and Eastern Europe by Swixx BioPharma

• Living Well with Fabry: Shared Decision-Making Toolkit by Chiesi with support from Rare Disease Research Partners

• Unseen Unheard: The Untold Breast Cancer Stories Of Black Women in the UK by Gilead Sciences with Black Women Rising with support from Mearns & Pike

• Gilead Community Awards: Driving Health Equity and Strengthening Communities by Gilead Sciences with support from 67health

• Cancer Equals by Bristol Myers Squibb with support from Aurora Healthcare Communications

• Meet the MPN 10 by Novartis UK with support from Havas Life Medicom with Havas Red
• GSK – “Shingles Denial” Campaign by GSK Australia with support from Orchard Marketing

• Charac by Charac with support from Sapience Communications

• Medscape Extend: Advanced Programmatic Targeting for Offsite HCP Engagement by Medscape
• novoMEDLINK.com by Novo Nordisk with support from Toolhouse
• AI Change Management – UCB X Syneos Health by UCB with support from Syneos Health Communications

• Building Mindset and Capabilities: Shaping the Amgen Marketers of 2030 by Amgen with support from Possible

• The Road To Change: A Global Capability Programme for Senior Marketers by AstraZeneca with support from Uptake
• Next Gen Rare: Upskilling Msls to Improve Rare Disease Patient Outcomes by Alexion with support from Uptake

• Regional Digital Media Centre of Excellence – New Way of Engaging with Patients and HCPs by Novo Nordisk with support from Kearney

• Embedding and Prioritising Patient Centricity and Engagement at Costello Medical by Costello Medical Consulting

• Driving Agility in Planning: Shaping the Amgen Marketers of 2030 by Amgen with support from Possible

• Roche-Government Cote d’Ivoire Partnership by Roche

• Providing Access to an Essential Epilepsy Medicine in Rwanda through a Sustainable and Inclusive Business Model by UCB

• WiNFUND: Real World Change. Right Now by Reckitt Benckiser with support from Havas SO
• A Rapid Response: Global Affordable Access to Diabetes Care by Sanofi with support from Uptake

• Possible

• IPG Health Medical Communications
• Mearns & Pike

• Aurora Healthcare Communications
• Syneos Health Communications
• The Studio

• Amgen